In This Article:
While recent shifts in bond yields have influenced the Canadian market, they also present opportunities for stronger fixed-income returns as interest rates adjust. In this context, penny stocks—though a somewhat outdated term—remain a relevant investment area, especially when backed by solid financials. These smaller or newer companies can offer unique growth prospects and value that larger firms might overlook, making them intriguing options for investors seeking under-the-radar opportunities with potential long-term benefits.
Top 10 Penny Stocks In Canada
Name | Share Price | Market Cap | Financial Health Rating |
Pulse Seismic (TSX:PSD) | CA$2.39 | CA$121.5M | ★★★★★★ |
Silvercorp Metals (TSX:SVM) | CA$4.32 | CA$939.87M | ★★★★★★ |
Mandalay Resources (TSX:MND) | CA$3.94 | CA$370M | ★★★★★★ |
Findev (TSXV:FDI) | CA$0.53 | CA$15.18M | ★★★★★★ |
PetroTal (TSX:TAL) | CA$0.54 | CA$492.49M | ★★★★★★ |
Foraco International (TSX:FAR) | CA$2.41 | CA$237.23M | ★★★★★☆ |
East West Petroleum (TSXV:EW) | CA$0.04 | CA$3.62M | ★★★★★★ |
NamSys (TSXV:CTZ) | CA$1.15 | CA$30.89M | ★★★★★★ |
Hemisphere Energy (TSXV:HME) | CA$1.83 | CA$178.48M | ★★★★★☆ |
Enterprise Group (TSX:E) | CA$1.89 | CA$116.34M | ★★★★☆☆ |
Click here to see the full list of 949 stocks from our TSX Penny Stocks screener.
We'll examine a selection from our screener results.
Microbix Biosystems
Simply Wall St Financial Health Rating: ★★★★★★
Overview: Microbix Biosystems Inc. is a life science company that develops and commercializes proprietary biological and technological solutions for human health across North America, Europe, and internationally, with a market cap of CA$55.59 million.
Operations: The company's revenue is primarily derived from its Antigens, QAPs, and DxTM segment, which generated CA$21.31 million.
Market Cap: CA$55.59M
Microbix Biosystems Inc., with a market cap of CA$55.59 million, has demonstrated significant revenue growth, reporting CA$25.39 million for the fiscal year ended September 2024, up from CA$16.51 million the previous year. The company has become profitable, posting a net income of CA$3.52 million compared to a loss in the prior year. Its financial health is bolstered by short-term assets exceeding liabilities and more cash than debt, with interest well covered by EBIT (16.7x). Recent strategic alliances and regulatory achievements in Europe further position Microbix for continued growth across its business lines.
-
Jump into the full analysis health report here for a deeper understanding of Microbix Biosystems.
-
Examine Microbix Biosystems' earnings growth report to understand how analysts expect it to perform.
Altamira Gold
Simply Wall St Financial Health Rating: ★★★★☆☆
Overview: Altamira Gold Corp. is involved in the acquisition, exploration, development, and mining of mineral properties in Brazil and Canada, with a market cap of CA$27.56 million.